Want to join the conversation?
Cambridge, Massachusetts-based $BIIB said opicinumab, a monoclonal antibody being developed as a potential neuroreparative therapy to treat people with relapsing forms of multiple sclerosis, has missed its primary endpoint. The company added that evidence of a clinical effect with a complex, unexpected dose-response was observed.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.